91 related articles for article (PubMed ID: 10934169)
1. Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas.
La Perle KM; Jhiang SM; Capen CC
Am J Pathol; 2000 Aug; 157(2):671-7. PubMed ID: 10934169
[TBL] [Abstract][Full Text] [Related]
2. Genomic alterations in thyroid cancer: biological and clinical insights.
Landa I; Cabanillas ME
Nat Rev Endocrinol; 2024 Feb; 20(2):93-110. PubMed ID: 38049644
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Insights of Thyroid Cancer Progression.
Leandro-García LJ; Landa I
Endocrinology; 2023 Aug; 164(9):. PubMed ID: 37503738
[TBL] [Abstract][Full Text] [Related]
4. Mouse Models to Examine Differentiated Thyroid Cancer Pathogenesis: Recent Updates.
Choi HR; Kim K
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446316
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of cancers derived from thyroid follicular cells.
Fagin JA; Krishnamoorthy GP; Landa I
Nat Rev Cancer; 2023 Sep; 23(9):631-650. PubMed ID: 37438605
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Models of Neuroendocrine Neoplasia.
Sedlack AJH; Saleh-Anaraki K; Kumar S; Ear PH; Lines KE; Roper N; Pacak K; Bergsland E; Quelle DE; Howe JR; Pommier Y; Del Rivero J
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428741
[TBL] [Abstract][Full Text] [Related]
7. Molecular therapeutics for anaplastic thyroid cancer.
Pozdeyev N; Rose MM; Bowles DW; Schweppe RE
Semin Cancer Biol; 2020 Apr; 61():23-29. PubMed ID: 31991166
[TBL] [Abstract][Full Text] [Related]
8. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
Nikitski AV; Rominski SL; Condello V; Kaya C; Wankhede M; Panebianco F; Yang H; Altschuler DL; Nikiforov YE
Thyroid; 2019 Oct; 29(10):1425-1437. PubMed ID: 31298630
[No Abstract] [Full Text] [Related]
9. Mouse Model of Poorly Differentiated Thyroid Carcinoma Driven by STRN-ALK Fusion.
Nikitski AV; Rominski SL; Wankhede M; Kelly LM; Panebianco F; Barila G; Altschuler DL; Nikiforov YE
Am J Pathol; 2018 Nov; 188(11):2653-2661. PubMed ID: 30125543
[TBL] [Abstract][Full Text] [Related]
10. Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene.
Monaco M; Palma G; Vitiello M; Capiluongo A; D'Andrea B; Vuttariello E; Luciano A; Cerchia L; Chiappetta G; Arra C; Fusco A; Fedele M
Cancers (Basel); 2018 Mar; 10(4):. PubMed ID: 29584698
[TBL] [Abstract][Full Text] [Related]
11. Mouse models of thyroid cancer: A 2015 update.
Kirschner LS; Qamri Z; Kari S; Ashtekar A
Mol Cell Endocrinol; 2016 Feb; 421():18-27. PubMed ID: 26123589
[TBL] [Abstract][Full Text] [Related]
12. Modeling anaplastic thyroid carcinoma in the mouse.
Champa D; Di Cristofano A
Horm Cancer; 2015 Feb; 6(1):37-44. PubMed ID: 25420535
[TBL] [Abstract][Full Text] [Related]
13. Modulation of sodium iodide symporter in thyroid cancer.
Lakshmanan A; Scarberry D; Shen DH; Jhiang SM
Horm Cancer; 2014 Dec; 5(6):363-73. PubMed ID: 25234361
[TBL] [Abstract][Full Text] [Related]
14. p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer.
McFadden DG; Vernon A; Santiago PM; Martinez-McFaline R; Bhutkar A; Crowley DM; McMahon M; Sadow PM; Jacks T
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1600-9. PubMed ID: 24711431
[TBL] [Abstract][Full Text] [Related]
15. Genetics and epigenetics of sporadic thyroid cancer.
Vu-Phan D; Koenig RJ
Mol Cell Endocrinol; 2014 Apr; 386(1-2):55-66. PubMed ID: 23933154
[TBL] [Abstract][Full Text] [Related]
16. Villous papillary thyroid carcinoma: a variant associated with marfan syndrome.
Winer DA; Winer S; Rotstein L; Asa SL; Mete O
Endocr Pathol; 2012 Dec; 23(4):254-9. PubMed ID: 22847364
[TBL] [Abstract][Full Text] [Related]
17. Mouse models of follicular and papillary thyroid cancer progression.
Russo MA; Antico Arciuch VG; Di Cristofano A
Front Endocrinol (Lausanne); 2011; 2():119. PubMed ID: 22654848
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in molecular diagnosis of thyroid cancer.
Legakis I; Syrigos K
J Thyroid Res; 2011; 2011():384213. PubMed ID: 21603167
[TBL] [Abstract][Full Text] [Related]
19. Mouse models of endocrine tumours.
Jones GN; Manchanda PK; Pringle DR; Zhang M; Kirschner LS
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):451-60. PubMed ID: 20833336
[TBL] [Abstract][Full Text] [Related]
20. Lessons from mouse models of thyroid cancer.
Kim CS; Zhu X
Thyroid; 2009 Dec; 19(12):1317-31. PubMed ID: 20001715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
